| GO category |
avg. LogFC |
p-value |
| Integral to lumenal side of endoplasmic reticulum membrane |
0.16 |
2.79E-04 |
| Cytokine-mediated signaling pathway |
0.27 |
3.28E-04 |
| Interferon-gamma-mediated signaling pathway |
0.21 |
3.56E-04 |
| MHC class I receptor activity |
0.16 |
7.82E-04 |
| Cytosolic small ribosomal subunit |
0.26 |
7.98E-03 |
| MHC class I protein complex |
0.16 |
1.04E-03 |
| Regulation of immune response |
0.22 |
1.33E-03 |
| Negative regulation of MAPK cascade |
0.20 |
1.34E-03 |
| Naïve + RIF |
| GO category |
avg. LogFC |
p-value |
| Mitotic cell cycle |
-0.37 |
1.53E-17 |
| DNA replication |
-0.34 |
2.59E-13 |
| Cell cycle checkpoint |
-0.36 |
4.98E-10 |
| S phase of mitotic cell cycle |
-0.32 |
6.29E-10 |
| DNA strand elongation involved in DNA replication |
-0.33 |
1.88E-09 |
| G1/S transition of mitotic cell cycle |
-0.36 |
2.02E-09 |
| Cell division |
-0.34 |
3.96E-09 |
| Cell cycle |
-0.32 |
2.26E-07 |
| hk-MTB + RIF |
| GO category |
avg. LogFC |
p-value |
| Melanosome |
0.26 |
4.09E-07 |
| Endoplasmic reticulum unfolded protein response |
0.29 |
7.95E-07 |
| Electron carrier activity |
0.23 |
9.11E-07 |
| Tissue regeneration |
-0.23 |
1.63E-05 |
| Response to drug |
-0.29 |
2.32E-05 |
| NADP binding |
0.22 |
3.07E-05 |
| Cellular lipid metabolic process |
-0.19 |
4.05E-05 |
| Lipid metabolic process |
-0.23 |
4.98E-05 |
|
|
|
|
|
|
|
